New Presentation of CD27 Deficiency; Coronary Ectasia and COVID-19
Abstract
CD27 is a costimulatory receptor involved in the maturation of the innate and adaptive immunity. CD27, through interaction with CD70, plays a role in the control of Epstein-Barr virus (EBV) infection. CD27 deficiency leads to an immune dysregulation disease characterized by EBV susceptibility. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might put patients with primary immunodeficiency at risk for adverse outcomes.
Chromogenic in situ hybridization (CISH) study was performed to detect EBV in the lymphoma tissue. Genetic analysis of the patient was done with Whole Exome Sequencing and detected variant was confirmed with PCR-Sanger sequencing.
Here we report a 20-month-old boy with CD27 deficiency who developed lymphoma and coronary artery ectasia and had been infected with SARS-CoV-2. Clinical and laboratory findings were incompatible with atypical Kawasaki syndrome or multisystem inflammatory syndrome in children (MIS-C).
As CD27 deficiency is a rare immune defect, publishing clinical data about the identified patient(s) can shed light on our knowledge about the related phenotype and the spectrum of clinical manifestations associated with CD27 deficiency. Thus, our findings expanded the spectrum of manifestations beyond EBV infection, highlighting this unusual cardiac sequela that could be related to EBV infection, lymphoma, or an underlying disease.
2. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24-64.
3. Mauracher AA, Gujer E, Bachmann LM, Güsewell S, Schmid JP. Patterns of immune dysregulation in primary immunodeficiencies: a systematic review. The Journal of Allergy and Clinical Immunology: In Practice. 2021;9(2):792-802. e10.
4. Redmond MT, Scherzer R, Prince BT. Novel Genetic Discoveries in Primary Immunodeficiency Disorders. Clin Rev Allergy Immunol. 2022:1-20.
5. Latour S, Fischer A. Signaling pathways involved in the T‐cell‐mediated immunity against Epstein‐Barr virus: Lessons from genetic diseases. Immunol Rev. 2019;291(1):174-89.
6. Tangye SG, Latour S. Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. Blood. 2020;135(9):644-55.
7. Flieswasser T, Van den Eynde A, Van Audenaerde J, De Waele J, Lardon F, Riether C, et al. The CD70-CD27 axis in oncology: the new kids on the block. J Exp Clin Cancer Res. 2022;41(1):1-15.
8. Lino CNR, Ghosh S. Epstein–Barr Virus in Inborn Immunodeficiency—More Than Infection. Cancers (Basel). 2021;13(19):4752.
9. Van Montfrans JM, Hoepelman AI, Otto S, Van Gijn M, Van De Corput L, De Weger RA, et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol. 2012;129(3):787-93. e6.
10. Ghosh S, Köstel Bal S, Edwards ES, Pillay B, Jiménez Heredia R, Erol Cipe F, et al. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood. 2020;136(23):2638-55.
11. Köse D, Güzelçiçek A, Öz Ö, Erdem AY, Haliloğlu Y, Witzel M, et al. The Mutation of CD27 Deficiency Presented With Familial Hodgkin Lymphoma and a Review of the Literature. J Pediatr Hematol Oncol. 2022;44(4):e833-e43.
12. Tangye SG, Palendira U, Edwards ES. Human immunity against EBV—lessons from the clinic. J Exp Med. 2017;214(2):269-83.
13. Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, et al. Consensus Middle East and North Africa Registry on inborn errors of immunity. J Clin Immunol. 2021;41(6):1339-51.
14. Giardino G, Romano R, Coppola E, Cillo F, Borzachiello C, De Luca M, et al. SARS-CoV-2 infection in the immunodeficient host: necessary and dispensable immune pathways. J Allergy Clin Immunol. 2021;9(9):3237-48.
15. Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021;147(2):520-31.
16. Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, et al. Fourth update on the Iranian National Registry of Primary Immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 2018;38(7):816-32.
17. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol. 2019;7(6):1763-70.
18. Alkhairy OK, Perez-Becker R, Driessen GJ, Abolhassani H, Van Montfrans J, Borte S, et al. Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol. 2015;136(3):703-12. e10.
19. Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 2019;21(1):243-51.
20. Abolhassani H, Hammarström L, Cunningham-Rundles C. Current genetic landscape in common variable immune deficiency. Blood. 2020;135(9):656-67.
21. Fang M, Abolhassani H, Lim CK, Zhang J, Hammarström L. Next generation sequencing data analysis in primary immunodeficiency disorders–future directions. J Clin Immunol. 2016;36(1):68-75.
Files | ||
Issue | Vol 22 No 1 (2023) | |
Section | Case Report(s) | |
DOI | https://doi.org/10.18502/ijaai.v22i1.12013 | |
Keywords | ||
CD27 deficiency COVID-19 Coronary ectasia EBV-associated lymphoma Multisystem inflammatory syndrome in children |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |